A Study of the Effect of a Moderate CYP3A Inducer Efavirenz on Quizartinib Pharmacokinetics in Healthy Participants

Clinical trial NCT04459598 · COMPLETED

Trial details

NCT number: NCT04459598
Sponsor: Daiichi Sankyo Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Drug-drug Interaction Pharmacokinetics Quizartinib

Start date: 2020-08-19
Primary completion: 2020-10-14
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.